Eiger Biopharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEiger Biopharmaceuticals

Eiger Biopharmaceuticals(EIGR)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Zokinvy	Lonafarnib	2022-07-18	2023-2024	Progeria , Laminopathies

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

chronic hepatitis

,

,

chronic hepatitis d

,

,

,

,

,

,

chronic hepatitis c

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

Sodium chloride

healthy volunteers/patients

,

,

major depressive disorder

,

depressive disorder

,

prostatic hyperplasia

,

,

knee osteoarthritis

,

,

,

,

carpal tunnel syndrome

,

,

premature birth

,

premature ejaculation

,

,

,

,

penile induration

,

,

thoracic outlet syndrome

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

musculoskeletal pain

,

systemic lupus erythematosus

,

,

,

,

dystonic disorders

,

,

myofascial pain syndromes

,

,

somatoform disorders

,

,

parkinson disease

,

temporomandibular joint disorders

,

,

temporomandibular joint dysfunction syndrome

,

,

systemic scleroderma

,

raynaud disease

,

localized scleroderma

,

diffuse scleroderma

,

urinary bladder diseases

,

multiple sclerosis

,

neurogenic urinary bladder

,

,

breast neoplasms

,

,

postoperative pain

,

breast diseases

,

hereditary breast and ovarian cancer syndrome

,

,

patellofemoral pain syndrome

,

,

chronic disease

,

overactive urinary bladder

,

muscle spasticity

,

,

migraine disorders

,

urinary incontinence

,

,

,

interstitial cystitis

,

,

,

,

wounds and injuries

,

,

,

,

,

graves ophthalmopathy

,

spinal cord injuries

,

microbial drug resistance

,

,

,

postoperative nausea and vomiting

,

bariatric surgery

,

,

,

keratoconjunctivitis sicca

,

dry eye syndromes

,

,

herpes labialis

,

breast implants

,

,

intraocular pressure

,

muscle strength

,

clostridium botulinum type a

,

,

healthy volunteers/patients

,

pancreatic neoplasms

,

,

,

pharyngeal neoplasms

,

fallopian tube neoplasms

,

,

,

head and neck neoplasms

,

colorectal neoplasms

,

brain neoplasms

,

rectal neoplasms

,

renal cell carcinoma

,

myelodysplastic syndromes

,

,

,

squamous cell carcinoma

,

disease progression

,

retinal diseases

,

diabetic retinopathy

,

,

,

kidney neoplasms

,

squamous cell carcinoma of head and neck

,

systemic scleroderma

,

,

interstitial lung diseases

,

localized scleroderma

,

diffuse scleroderma

,

,

hemangiosarcoma

,

breast neoplasms

,

,

non-small-cell lung carcinoma

,

,

,

,

,

lupus nephritis

,

systemic lupus erythematosus

,

,

chronic urticaria

,

,

ovarian neoplasms

,

non-hodgkin lymphoma

,

diabetes mellitus

,

retinal vein occlusion

,

central venous catheters

,

triple negative breast neoplasms

,

stomach neoplasms

,

,

cerebral hemorrhage

,

,

neoplasm metastasis

,

rheumatoid arthritis

,

,

macular degeneration

,

wet macular degeneration

,

follicular lymphoma

,

,

,

cerebral intraventricular hemorrhage

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

pulmonary arterial hypertension

,

familial primary pulmonary hypertension

,

,

chronic hepatitis b

,

,

,

,

,

,

,

hyperlipidemias

,

,

hyperlipoproteinemias

,

cardiovascular diseases

,

hypercholesterolemia

type 2 diabetes mellitus

,

diabetes mellitus

,

healthy volunteers/patients

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use